Bioelectronics Corp (BIEL)

[srinsocal]

It should not take long to modify the Full Body 510k to a Female Full Body 510k. That is a priority. Postoperative Pain and Menstrual Pain will follow.

With Mundipharma now in charge of Australia and several Asian markets I am looking for rapid growth there.

There are many other projects ongoing but it is hard to say how today's news affects them. CVS and VA are both Knee Deals and ActiPatch already has FDA Knee Clearance.

The 3 large outbound shipments that were mentioned are headed overseas where ActiPatch already has Full Body use approval.

Embracing this statistical advantage ActiPatch has with women should also be considered IMO.

I am of the male gender and ActiPatch has worked well on my back pain for the last 10 years. If a tweak in frequency/power/pulse rate is needed to achieve better efficacy in males, so be it. A His and Hers version of products is not uncommon.